Suppr超能文献

针对黏液瘤病毒感染的疫苗接种策略:我们真的做到最好了吗?

Vaccination strategies against myxomavirus infections: are we really doing the best?

作者信息

Marlier D

机构信息

Department of Bird, Rabbit and Rodent Medicine, Faculty of Veterinary Medicine, University of Liège, Bld de Colonster 20, Bat B42, Sart-Tilman, B4000 Liège.

出版信息

Tijdschr Diergeneeskd. 2010 Mar 1;135(5):194-8.

Abstract

Vaccination is the best way to control myxomatosis in both pet and production rabbits. Two types of myxomatosis vaccines are commercially available, namely, a vaccine prepared from the Shope fibroma virus (SFV) and one prepared from an attenuated myxoma virus (MV) strain, e.g., SG33. The first one is weakly immunogenic and provides only short-term protection whereas atypical reactions have been described with the second one. This short review describes the vaccine strains and provides some data on the host-virus relationship, resistance, and immunity in myxomatosis. In the last section, recommended myxomatosis vaccination schemes for production and pet animals are presented.

摘要

接种疫苗是控制宠物兔和商品兔黏液瘤病的最佳方法。市面上有两种黏液瘤病疫苗,一种是由肖普纤维瘤病毒(SFV)制备的疫苗,另一种是由减毒黏液瘤病毒(MV)株(如SG33)制备的疫苗。第一种免疫原性较弱,只能提供短期保护,而第二种疫苗则出现过非典型反应。这篇简短的综述介绍了疫苗毒株,并提供了一些关于黏液瘤病中宿主与病毒关系、抵抗力和免疫力的数据。在最后一部分,给出了针对商品兔和宠物兔的推荐黏液瘤病疫苗接种方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验